Cargando…

Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect

FBXO7 is implicated in the ubiquitin–proteasome system and parkin‐mediated mitophagy. FBXO7defects cause a levodopa‐responsive parkinsonian‐pyramidal syndrome(PPS). Methods: We investigated the disease molecular bases in a child with PPS and brain iron accumulation. Results: A novel homozygous c.368...

Descripción completa

Detalles Bibliográficos
Autores principales: Correa‐Vela, Marta, Lupo, Vincenzo, Montpeyó, Marta, Sancho, Paula, Marcé‐Grau, Anna, Hernández‐Vara, Jorge, Darling, Alejandra, Jenkins, Alison, Fernández‐Rodríguez, Sandra, Tello, Cristina, Ramírez‐Jiménez, Laura, Pérez, Belén, Sánchez‐Montáñez, Ángel, Macaya, Alfons, Sobrido, María J., Martinez‐Vicente, Marta, Pérez‐Dueñas, Belén, Espinós, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448169/
https://www.ncbi.nlm.nih.gov/pubmed/32767480
http://dx.doi.org/10.1002/acn3.51095
_version_ 1783574447638183936
author Correa‐Vela, Marta
Lupo, Vincenzo
Montpeyó, Marta
Sancho, Paula
Marcé‐Grau, Anna
Hernández‐Vara, Jorge
Darling, Alejandra
Jenkins, Alison
Fernández‐Rodríguez, Sandra
Tello, Cristina
Ramírez‐Jiménez, Laura
Pérez, Belén
Sánchez‐Montáñez, Ángel
Macaya, Alfons
Sobrido, María J.
Martinez‐Vicente, Marta
Pérez‐Dueñas, Belén
Espinós, Carmen
author_facet Correa‐Vela, Marta
Lupo, Vincenzo
Montpeyó, Marta
Sancho, Paula
Marcé‐Grau, Anna
Hernández‐Vara, Jorge
Darling, Alejandra
Jenkins, Alison
Fernández‐Rodríguez, Sandra
Tello, Cristina
Ramírez‐Jiménez, Laura
Pérez, Belén
Sánchez‐Montáñez, Ángel
Macaya, Alfons
Sobrido, María J.
Martinez‐Vicente, Marta
Pérez‐Dueñas, Belén
Espinós, Carmen
author_sort Correa‐Vela, Marta
collection PubMed
description FBXO7 is implicated in the ubiquitin–proteasome system and parkin‐mediated mitophagy. FBXO7defects cause a levodopa‐responsive parkinsonian‐pyramidal syndrome(PPS). Methods: We investigated the disease molecular bases in a child with PPS and brain iron accumulation. Results: A novel homozygous c.368C>G (p.S123*) FBXO7 mutation was identified in a child with spastic paraplegia, epilepsy, cerebellar degeneration, levodopa nonresponsive parkinsonism, and brain iron deposition. Patient’s fibroblasts assays demonstrated an absence of FBXO7 RNA expression leading to impaired proteasome degradation and accumulation of poly‐ubiquitinated proteins. Conclusion: This novel FBXO7 phenotype associated with impaired proteasome activity overlaps with neurodegeneration with brain iron accumulation disorders.
format Online
Article
Text
id pubmed-7448169
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74481692020-08-31 Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect Correa‐Vela, Marta Lupo, Vincenzo Montpeyó, Marta Sancho, Paula Marcé‐Grau, Anna Hernández‐Vara, Jorge Darling, Alejandra Jenkins, Alison Fernández‐Rodríguez, Sandra Tello, Cristina Ramírez‐Jiménez, Laura Pérez, Belén Sánchez‐Montáñez, Ángel Macaya, Alfons Sobrido, María J. Martinez‐Vicente, Marta Pérez‐Dueñas, Belén Espinós, Carmen Ann Clin Transl Neurol Brief Communication FBXO7 is implicated in the ubiquitin–proteasome system and parkin‐mediated mitophagy. FBXO7defects cause a levodopa‐responsive parkinsonian‐pyramidal syndrome(PPS). Methods: We investigated the disease molecular bases in a child with PPS and brain iron accumulation. Results: A novel homozygous c.368C>G (p.S123*) FBXO7 mutation was identified in a child with spastic paraplegia, epilepsy, cerebellar degeneration, levodopa nonresponsive parkinsonism, and brain iron deposition. Patient’s fibroblasts assays demonstrated an absence of FBXO7 RNA expression leading to impaired proteasome degradation and accumulation of poly‐ubiquitinated proteins. Conclusion: This novel FBXO7 phenotype associated with impaired proteasome activity overlaps with neurodegeneration with brain iron accumulation disorders. John Wiley and Sons Inc. 2020-08-06 /pmc/articles/PMC7448169/ /pubmed/32767480 http://dx.doi.org/10.1002/acn3.51095 Text en © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Correa‐Vela, Marta
Lupo, Vincenzo
Montpeyó, Marta
Sancho, Paula
Marcé‐Grau, Anna
Hernández‐Vara, Jorge
Darling, Alejandra
Jenkins, Alison
Fernández‐Rodríguez, Sandra
Tello, Cristina
Ramírez‐Jiménez, Laura
Pérez, Belén
Sánchez‐Montáñez, Ángel
Macaya, Alfons
Sobrido, María J.
Martinez‐Vicente, Marta
Pérez‐Dueñas, Belén
Espinós, Carmen
Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect
title Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect
title_full Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect
title_fullStr Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect
title_full_unstemmed Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect
title_short Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect
title_sort impaired proteasome activity and neurodegeneration with brain iron accumulation in fbxo7 defect
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448169/
https://www.ncbi.nlm.nih.gov/pubmed/32767480
http://dx.doi.org/10.1002/acn3.51095
work_keys_str_mv AT correavelamarta impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT lupovincenzo impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT montpeyomarta impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT sanchopaula impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT marcegrauanna impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT hernandezvarajorge impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT darlingalejandra impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT jenkinsalison impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT fernandezrodriguezsandra impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT tellocristina impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT ramirezjimenezlaura impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT perezbelen impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT sanchezmontanezangel impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT macayaalfons impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT sobridomariaj impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT martinezvicentemarta impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT perezduenasbelen impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect
AT espinoscarmen impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect